ArticleJournal of computer-aided molecular design2025
Comparison study of dominant molecular sequence representation based on diffusion model.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhancing ADMET property predictions using cross-aligned multimodal attention mechanisms.Molecular diversity · 2026Article
- Molecular sonification: a multi-modal approach for enhanced ai in drug discovery.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026Article
- Artificial intelligence in drug discovery from advanced molecular representation to pipeline applications.Frontiers in bioinformatics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In recent years, the emergence of large language models (LLMs), particularly the advent of ChatGPT, has positioned natural language sequence-based representation learning and generative models as the dominant research paradigm in AI for science. Within the domains of drug discovery and computational chemistry, compound representation learning and molecular generation stand out as two of the most significant tasks. Currently, the predominant molecular representation sequences used for molecular characterization and generation include SMILES (Simplified Molecular-Input Line-Entry System), SELFIES (SELF-referencing Embedded Strings), SMARTS (Smiles Arbitrary Target Specification), and IUPAC (International Union of Pure and Applied Chemistry) nomenclature. In the context of AI-assisted drug design, each of these molecular languages has its own strengths and weaknesses, and the granularity of information encoded by different molecular representation forms varies significantly. However, the selection of an appropriate molecular representation as the input format for model training is crucial, yet this issue has not been thoroughly explored. Furthermore, the state-of-the-art models currently employed for molecular generation and optimization are diffusion models. Therefore, this study investigates the characteristics of the four mainstream molecular representation languages within the same diffusion model for training generative molecular sets. First, a single molecule is represented in four different ways through varying methodologies, followed by training a denoising diffusion model using identical parameters. Subsequently, thirty thousand molecules are generated for evaluation and analysis. The results indicate that the four molecular representation languages exhibit both similarities and differences in attribute distribution and spatial distribution; notably, SELFIES and SMARTS demonstrate a high degree of similarity, while IUPAC and SMILES show substantial differences. Additionally, IUPAC's primary advantage lies in the novelty and diversity of generated molecules, whereas SMILES excels in QEPPI and SAscore metrics, with SELFIES and SMARTS performing best on the QED metric. The findings of this research will provide crucial insights into the selection of molecular representations in AI drug design tasks, thereby contributing to enhanced efficiency in drug development.
Indexed as
Identifiers
40679539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.